Abstract
Background
Susac Syndrome (SuS) is an autoimmune endotheliopathy impacting the brain, retina and cochlea that can clinically mimic multiple sclerosis (MS).
Objective
To evaluate non-lesional white matter demyelination changes in SuS compared to MS and healthy controls (HC) using quantitative MRI.
Methods
3T MRI including myelin water imaging and diffusion basis spectrum imaging were acquired for 7 SuS, 10 MS and 10 HC participants. Non-lesional white matter was analyzed in the corpus callosum (CC) and normal appearing white matter (NAWM). Groups were compared using ANCOVA with Tukey correction.
Results
SuS CC myelin water fraction (mean 0.092) was lower than MS(0.11, p = 0.01) and HC(0.11, p = 0.04). Another myelin marker, radial diffusivity, was increased in SuS CC(0.27μm2/ms) compared to HC(0.21μm2/ms, p = 0.008) and MS(0.23μm2/ms, p = 0.05). Fractional anisotropy was lower in SuS CC(0.82) than HC(0.86, p = 0.04). Fiber fraction (reflecting axons) did not differ from HC or MS. In NAWM, radial diffusivity and apparent diffusion coefficient were significantly increased in SuS compared to HC(p < 0.001 for both measures) and MS(p = 0.003, p < 0.001 respectively).
Conclusions
Our results provided evidence of myelin damage in SuS, particularly in the CC, and more extensive microstructural injury in NAWM, supporting the hypothesis that there are widespread microstructural changes in SuS syndrome including diffuse demyelination.
Keywords: Susac syndrome, MRI, neuroimaging, multiple sclerosis, myelin water imaging, diffusion basis spectrum imaging, demyelination
Introduction
Susac Syndrome (SuS) is a rare autoimmune endotheliopathy of the brain, retina and cochlea.1,2 It causes branch retinal artery occlusions, hearing loss, and protean central nervous system dysfunction. Snowball-like lesions in the corpus callosum (CC) can be observed on conventional magnetic resonance imaging (MRI) scans. 1 SuS is a clinical mimic of multiple sclerosis (MS).
Relatively little is known about the microstructural brain damage in SuS. One reported case with brain biopsy showed demyelination in the perivenular white matter (WM) with relative preservation of axons. 3 Advanced MRI techniques can be used to probe tissue damage in SuS non-invasively. Myelin water imaging (MWI) can be used to measure the myelin water fraction (MWF), the ratio of magnetic resonance signal from the water between the myelin bilayers to the total water signal. 4 MWF has been histopathologically validated as being a myelin-specific marker in human post-mortem tissue as well as preclinical models.4,5 Diffusion Tensor Imaging (DTI) is sensitive to microstructural architecture and reflects not only myelin, but also fibre coherence, axonal density, and membrane permeability.6,7 Previous DTI studies demonstrated decreased fiber integrity of the non-lesional WM in SuS patients, particularly in the CC, compared to healthy controls (HC).8,9 Diffusion basis spectrum imaging (DBSI) is a recent advancement on DTI that can simultaneously quantify axonal injury, myelination, inflammation and oedema by modeling myelinated and unmyelinated axons as anisotropic diffusion tensors, and cells and extracellular space as isotropic diffusion tensors. 10 Traditional DTI measurements can be extracted from DBSI with improved sensitivity and specificity since the confounding effects of inflammation are independently modeled as isotropic diffusion tensors. Fractional anisotropy (FA) is a measure of the degree of anisotropic diffusion of the water molecules; 11 generally, reduced FA is associated with WM damage. 11 Radial diffusivity (RD) increases with myelin damage. 10 The apparent diffusion coefficient (ADC) measures overall diffusion and is indicative of non-specific overall tissue damage. 12 DBSI additionally estimates several other parameters. The fiber fraction (FF) measures fiber density and is a marker of axonal integrity. 10 The hindered isotropic fraction (HIF) is thought to represent water accumulation in the extra-cellular space which could be representative of edema. 12 The restricted isotropic fraction (RIF) refers to intra-cellular water, which is found in microglia and other inflammatory cells. 10 Axial diffusivity (AD) is another measure extracted from DBSI, however this measure has not been associated with a particular pathology in demyelinating diseases. 13
Myelin loss in normal appearing white matter (NAWM) in Susac syndrome has not been previously investigated, or reported outside the brain biopsy. 3 Our study used advanced MRI to more specifically investigate the biological underpinnings of previously reported decreased fractional anisotropy in SuS. 9 We hypothesize that the macrostructural changes observed in SuS are due to myelin loss both within the CC and diffusely throughout the NAWM. Thus, we investigated MWF and DBSI metrics in the CC and NAWM in SuS compared to MS and HC.
Materials and methods
Participants
Seven participants with SuS were recruited for this study: 2 with definite SuS and 5 with probable SuS following the proposed European Susac Consortium diagnostic criteria. 14 Data was also collected from 10 MS (MS subtype: 8 relapsing-remitting, 1 primary progressive, 1 sary progressive) and 20 HC participants (Table 1). The HC group was collated from 2 different studies such that 10 HC had DBSI data, and 10 HC had MWI data. There was no overlap between HC groups. All studies were approved by the University of British Columbia Clinical Research Ethics Board and all participants provided written informed consent.
Table 1.
Participant demographic information at the time of the MRI scan.
Cohort | N | Mean Age | Sex (F:M) | Mean Disease Duration | Median EDSS |
---|---|---|---|---|---|
SuS | 7 | 43.5y (range 29-78) | 6:1 | 6.6y (range 2-12) | 3.0 (range 1.5-6.0) |
MS | 10 | 43.2y (range 26-70) | 9:1 | 14.7y (range 3-33) | 2.0 (range 0-6.5) |
HC (DBSI) | 10 | 35.9y (range 22-47) | 5:5 | N/A | N/A |
HC (MWI) | 10 | 44.0y (range 27-64) | 9:1 | N/A | N/A |
MRI
MRI scans were performed using a Philips Achieva 3.0T system (Philips Healthcare, Best, Netherlands) with an 8-channel SENSE head coil. MWI data were acquired with a 48-echo 3D gradient and spin echo (GRASE) sequence (TR = 1073 ms, echo spacing = 8 ms, 20 slices acquired at 1 × 2 × 5 mm reconstructed to 40 slices at 1 × 1 × 2.5 mm3). 15 DBSI data were acquired with echo-planar diffusion weighted sequence with 99 diffusion encoding directions (range of b-values 0–1500s/mm2, TR = 4943ms, TE = 85ms, voxel size = 2 × 2x2mm3, 40 slices). A 3DT1-weighted scan (whole–brain 3D magnetization–prepared rapid gradient–echo (MPRAGE), TR = 3000 ms, inversion time (TI) = 1072 ms, 1 × 1 × 1 mm3 voxel, 160 slices) was collected for tissue segmentation and spatial normalization. Sample images of 3DT1, MWI, and DBSI-derived ADC shown in Figure 1.
Figure 1.
Representative MRI from susac syndrome, multiple sclerosis (MS) and a healthy control (HC). The 3DT1 is used as an anatomical image. The myelin water fraction (MWF) image reflects myelin content (hotter for more myelin). 4 The apparent diffusion coefficient (ADC) is a measure extracted from diffusion basis spectrum imaging measuring overall diffusion and is indicative of non-specific overall tissue damage. 12
Analysis
MWF maps were generated from the GRASE sequence using an in-house regularized non-negative least-squares fitting algorithm with stimulated echo correction. 16 MWF was calculated as the area under the T2 relaxation curve with times between 15 ms and 40 ms over the total area under the T2 distribution. 15 Eddy current correction on the diffusion data was performed using the FMRIB’s FSL tool Top-up. 17 The corrected DBSI data was analyzed using an in-house Matlab package which generated metric maps of FA, RD, AD, ADC, FF, HIF, and RIF12,16
Non-lesional NAWM masks were created using a method previously applied in MS studies. 18 All images were registered to the GRASE 1st echo image using FMRIB’s Linear Image Registration Tool (FLIRT) transformation with 9 degrees of freedom. 19 Non-lesional NAWM masks were created using an automated brain segmentation algorithm (FAST) from the 3DT1 images using 3 voxel classes.18,20 A neurologist (RC) confirmed that the creation of non-lesional NAWM masks removed all T2-hyperintense lesions in the corpus callosum in SuS. 1 to 2 small (<1mm) non-specific lesions were included in each mask, however as they are so small, they do not drive the results. The 3DT1 images were registered to MNI (standard template) space using FMRIB’s Non-Linear Image Registration Tool (FNIRT) with 12 degrees of freedom. 21 The CC ROIs obtained from the JHU atlas were then warped to GRASE space and multiplied by the WM mask to ensure proper registration of the ROIs and to exclude lesions. 22
Statistical Analysis
Participant demographics were compared using one-way ANOVA. SuS, MS, and HC values for MWF and DBSI metrics were compared using ANCOVA with age as a covariate with a Tukey comparison for multiple groups to correct for false positives. Disease duration was not included as a covariate since age and disease duration were colinear. Homogeneity of variance of the measures was tested with Levene’s test Normality of the measures was tested with the Shapiro-Wilks test Statistical significance was defined as p < 0.05.
Results
Participant demographics are shown in Table 1. Age was not significantly different between groups. SuS and MS groups were matched for EDSS. The MS group had a longer disease duration (p = 0.03).
There were no significant differences detected in any MRI metric between definite and probable SuS (Student’s t-test p > 0.05). The variances of all measures were homogenous. All metrics in each population were normal except FF(SuS) and ADC(HC). FF was analyzed with non-parametric ANCOVA and the difference was not significant (p = 0. 12). One outlier in the HC population violated normality; removing this data point allowed the population to conform to normality and did not change the ANCOVA results (significance values do not change to the third decimal point). Mean MRI metrics and p-values for comparisons between groups are reported in Table 2, with boxplots illustrating group differences for each MRI metric between groups for CC in Figure 2 and NAWM in Figure 3.
Table 2.
Table of corpus Callosum results and normal appearing white matter results.
Healthy Controls | Susac Syndrome | p-value SuS vs HC | Multiple Sclerosis | p-value SuS vs MS | |
---|---|---|---|---|---|
Corpus Callosum | |||||
MWF | 0.11 ± 0.02 | 0.092 ± 0.01 | p = 0.04 | 0.11 ± 0.02 | p = 0.01 |
RD μm2/ms | 0.21 ± 0.03 | 0.27 ± 0.01 | p = 0.008 | 0.23 ± 0.05 | p = 0.05 |
FA | 0.86 ± 0.02 | 0.82 ± 0.02 | p = 0.04 | 0.85 ± 0.04 | p = 0.2 |
ADC μm2/ms | 0.71 ± 0.04 | 0.84 ± 0.08 | p < 0.001 | 0.73 ± 0.04 | p < 0.001 |
FF | 0.72 ± 0.05 | 0.69 ± 0.03 | p = 0.6 | 0.73 ± 0.09 | p = 0.4 |
RIF | 0.037 ± 0.007 | 0.030 ± 0.004 | p = 0.1 | 0.034 ± 0.008 | p = 0.4 |
HIF | 0.11 ± 0.04 | 0.12 ± 0.002 | p = 0.99 | 0.12 ± 0.07 | p = 0.99 |
Normal Appearing White Matter | |||||
MWF | 0.11 ± 0.02 | 0.096 ± 0.01 | p = 0.12 | 0.12 ± 0.02 | p = 0.023 |
RD μm2/ms | 0.29 ± 0.01 | 0.33 ± 0.02 | p < 0.001 | 0.30 ± 0.01 | p = 0.003 |
FA | 0.78 ± 0.01 | 0.76 ± 0.01 | p = 0.08 | 0.77 ± 0.02 | p = 0.3 |
ADC μm2/ms | 0.68 ± 0.02 | 0.74 ± 0.04 | p < 0.001 | 0.69 ± 0.02 | p < 0.001 |
FF | 0.64 ± 0.03 | 0.63 ± 0.03 | p > 0.05 | 0.65 ± 0.02 | p > 0.05 |
RIF | 0.054 ± 0.004 | 0.046 ± 0.006 | p = 0.01 | 0.051 ± 0.005 | p = 0.08 |
HIF | 0.19 ± 0.03 | 0.19 ± 0.009 | p = 0.99 | 0.18 ± 0.02 | p = 0.6 |
Legend: Myelin Water Fraction (MWF) decreases with demyelination; Radial Diffusivity (RD) increases with myelin damage; Fractional Anisotropy (FA) decreases with demyelination and axonal damage; Apparent Diffusion Coefficient (ADC) increases with overall tissue damage; Fiber Fraction (FF) decreases with loss of axons; Restricted Isotropic Fraction (RIF) increases with increased cellularity (e.g. microglia or inflammation); Hindered Isotropic Fraction (HIF) increases with edema. BOLD for significant differences between cohorts.
Figure 2.
Advanced imaging results for the corpus callosum (CC) for controls (HC), multiple sclerosis (MS) and susac syndrome (SuS) participants. Significant results are a) Myelin water fraction (MWF). MWF of the CC of SuS (0.092 ± 0.01) was significantly lower than HC (0.11 ± 0.02) (p = 0.04) MS (0.11 ± 0.02) (p = 0.01). b) Radial diffusivity (RD). RD in SuS (0.27 ± 0.03) was significantly higher compared to HC (0.21 ± 0.01) (p = 0.008) and MS (0.23 ± 0.05) (p = 0.05). c) Fractional anisotropy (FA). FA of SuS (0.82 ± 0.02) was significantly lower than HC (0.86 ± 0.02) (p = 0.04). d) Apparent diffusion coefficient (ADC). ADC in the CC of SuS (0.84 ± 0.08) was significantly increased compared to MS (0.73 ± 0.04) and controls (0.71 ± 0.04) (p < 0.001 for both). * p < 0.01, ** p < 0.001.
Figure 3.
Advanced MRI results for white matter of the whole brain for controls (HC), multiple sclerosis (MS) and susac syndrome (SuS) participants. Significant results are a) Myelin water fraction of white matter. SuS is lower than MS (0.11 ± 0.02) (p = 0.02) b) Radial diffusivity (RD) of white matter. RD is higher in SuS (0.33 ± 0.02) compared to HC (0.29 ± 0.01) (p < 0.001) and MS (0.30 ± 0.01) (p = 0.003). d) The apparent diffusion coefficient (ADC) of white matter. SuS (0.74 ± 0.04) ADC is higher than HC (0.68 ± 0.01) (p < 0.001) and MS (0.69 ± 0.02) (p < 0.001). g) Restricted isotropic fraction (RIF) of white matter. SuS (0.046 ± 0.006) RIF is lower compared to HC (0.054 ± 0.004) (p = 0.01). * p < 0.01, ** p < 0.001.
Sus vs HC
Myelin metrics: CC MWF was 16% lower in the SuS group (mean ± standard deviation = 0.092 ± 0.01) compared to HC (0.11 ± 0.02, p = 0.04) (Figure 2(a)) while NAWM MWF demonstrated a trend-level 13% reduction (p = 0.1, Figure 3(a))). RD was 15% higher in SuS CC compared to HC (SuS 0.27 ± 0.03 μm2/ms vs HC 0.21 ± 0.01 μm2/ms, p = 0.008 (Figure 2(b))) and 12% higher in NAWM (SuS 0.33 ± 0.02 vs HC 0.29 ± 0.01 μm2/ms, p < 0.001) (Figure 3(b)).
Tissue integrity metrics: The FA of SuS CC (0.82 ± 0.02) was 5% lower than HC (0.86 ± 0.02, p = 0.02) (Figure 2(c)) and demonstrated a trend-level 3% reduction in NAWM (p = 0.08) (Figure 3(c)). ADC was 15% higher in the CC (0.84 ± 0.08 vs 0.71 ± 0.04 μm2/ms, p < 0.001) and 8% higher in NAWM (0.74 ± 0.04 vs 0.68 ± 0.02 μm2/ms, p < 0.001) for SuS compared to controls (Figure 3(d)).
Axonal metric: FF did not differ between SuS and HC.
Sus vs MS
Compared to MS, there was lower MWF and a higher RD and ADC in the CC and the NAWM while the NAWM only showed a lower MWF and higher RD and ADC for SuS (Table 2). FF did not differ between SuS and MS.
Discussion
We investigated the extent and nature of any damage to non-lesional white matter tissue in SuS. In this study, SuS patients had increased ADC values in non-lesion CC and NAWM and lower FA in the CC, which is consistent with the decreased fiber integrity described in earlier studies.8,9 The increased RD in both the CC and NAWM and the trend of decreased MWF in the CC suggests that demyelination contributes to the pathology of Susac syndrome. While in an increase in RD is generally related to a decrease in myelin, the increase in RD in the NAWM can also be attributed to tissue ischemia without the corroborating MWF results. FF, which represents fiber density, a putative axonal biomarker, was not significantly decreased in this small cohort, suggesting that axon integrity is relatively preserved. Nor was there evidence of global edema (increase in hindered isotropic fraction) or an increase in inflammatory cells (restricted isotropic fraction). Taken together, these findings increase the specificity of previous DTI findings and are consistent with the previous brain biopsy study, which showed demyelination with relative preservation of axons in SuS CC. 3
This study had a few limitations. The sample size was small as the diagnosis is rare. Another limitation is that the MS group had a significantly longer disease duration than the SuS group, which is a discrepancy between the groups. Despite the longer disease duration in MS, SuS showed greater changes in the MRI parameters, strengthening the interpretation of increased tissue damage (particularly myelin) in SuS compared to MS. The DBSI controls contained a different sex ratio compared to the SuS and MS groups. Previous studies have not found sex dependent differences in the diffusion tensor metrics except FA, where some regions of the corpus callosum show higher FA for each sex. 23 The MWF showed this same regional dependency, however no conclusion was drawn for the whole CC. 23 Furthermore, more extensive MWI studies have not shown sex dependent myelin content differences in HC or MS.24,25 MWF was not significantly decreased in SuS NAWM compared to healthy controls; this is likely due the large amount of heterogeneity in myelin across NAWM and between individuals, thus sometimes requiring large groups or severe disease courses to find group differences cross-sectionally. 26 Similarly, this study did not detect a significant decrease in MS NAWM compared to HC, which is in contrast to some previous studies,27,28 but is not consistently the case, depending on group size, age, disease severity, etc.. 18 MWF varies greatly between regions and individuals including healthy controls, and thus differences can be washed out when looking across a large heterogeneous ROI such as all NAWM. 18 When narrowing the scope from NAWM to the CC, a region frequently involved in both SuS and MS, the trend toward decreased MWF supports the finding of more myelin damage in SuS.
This study supports the hypothesis that the microstructural damage observed in the CC of SuS patients includes demyelination. The NAWM results illustrate more widespread injury rather than injury focused in the CC. The two mechanisms of injury could either be demyelination or tissue ischemia. Existing data suggests that myelin loss potentially occurs as a secondary process and is a downstream consequence of damage to endothelial cells.3,29 Myelin damage has been found near injured blood vessels, which could suggest that demyelination is an epiphenomenon of autoimmune endotheliopathy. However, more brain biopsies are required to confirm this finding.
In patients with probable or definite SuS, the finding of diffuse myelin injury is a novel feature, providing further insight into the scope of the disease; in that it can affect the whole brain rather than only areas associated with T2 hyperintense lesions. Future natural history and treatment studies of Sus may want to consider advanced imaging measures such as MWI and DWI to monitor global damage not evident on conventional MRI.
Acknowledgements
The authors would like to thank the participants and the MRI technologists at the UBC MRI Research Centre. We would like to thank Dr Woolfenden for his recruitment of Susac participants for our study. We thank Carolyn Taylor (UBC Applied Statistics and Data Science Group) for helpful discussions.
Footnotes
Declaration of conflicting interests: PJ, IV, SA, LL, HY, CL, and AW have nothing to disclose. JC has fellowship funding from Biogen. She has consulted for Roche. AT received funding from Chugai, Roche, Novartis, Genzyme, Biogen. He has received honoraria from Genzyme, Roche, Teva, Biogen and Serono. DL is the Emeritus Director of the UBC MS/MRI Research Group which has been contracted to perform central analysis of MRI scans for therapeutic trials with Roche and Sanofi-Genzyme. The UBC MS/MRI Research Group has also received grant support for investigator-initiated independent studies from Genzyme, Novartis and Roche. He has acted as a consultant to Vertex Pharmaceuticals and served on the Scientific Advisory Boards for Adelphi Group, Biogen and Celgene. He has given lectures which have been supported by non-restricted education grants from Academy of Health Care Learning, Consortium of MS Centers and Sanofi-Genzyme. RT has received research support as part of sponsored clinical studies from Novartis, Roche and Sanofi Genzyme. RC is a site investigator for studies funded by Novartis, MedImmune and Roche and receives research support from Teva Innovation Canada, Roche Canada and Vancouver Coastal Health Research Institute. He has done consulting work and has received honoraria from Roche, EMD Serono, Sanofi, Biogen, Novartis and Teva. SK has received research funding from Sanofi Genzyme and F. Hoffmann La Roche.
Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Multiple Sclerosis Society of Canada (grant number 2302, 3031).
ORCID iDs: P Johnson https://orcid.org/0000-0003-4153-428X
IM Vavasour https://orcid.org/0000-0001-9286-0953
S Abel https://orcid.org/0000-0001-8547-1415
LE Lee https://orcid.org/0000-0002-8334-3740
RL Carruthers https://orcid.org/0000-0001-7085-1001
Contributor Information
JK Chan, Department of Medicine (Neurology), University of British Columbia, Canada.
IM Vavasour, Department of Radiology, University of British Columbia, Canada; International Collaboration on Repair Discoveries (ICORD).
H Yong, Department of Medicine (Neurology), University of British Columbia, Canada.
C Laule, Department of Radiology, University of British Columbia, Canada; International Collaboration on Repair Discoveries (ICORD); Department of Pathology and Laboratory Medicine, University of British Columbia, Canada; Department of Physics and Astronomy, University of British Columbia, Canada.
DKB Li, Department of Medicine (Neurology), University of British Columbia, Canada; Department of Radiology, University of British Columbia, Canada.
R Tam, Department of Radiology, University of British Columbia, Canada; School of Biomedical Engineering, University of British Columbia, Canada.
RL Carruthers, Department of Medicine (Neurology), University of British Columbia, Canada.
SH Kolind, Department of Medicine (Neurology), University of British Columbia, Canada; Department of Radiology, University of British Columbia, Canada; International Collaboration on Repair Discoveries (ICORD); Department of Physics and Astronomy, University of British Columbia, Canada.
References
- 1.Dörr J, Krautwald S, Wildemann B, et al. Characteristics of susac syndrome: a review of all reported cases. Nat Rev Neurol 2013; 9: 307–316. [DOI] [PubMed] [Google Scholar]
- 2.Buzzard KA, Reddel SW, Yiannikas Cet al. et al. Distinguishing susac’s syndrome from multiple sclerosis. J Neurol 2015; 262: 1613–1621. [DOI] [PubMed] [Google Scholar]
- 3.Ryerson LZ, Kister I, Snuderl Met al. et al. Incomplete susac syndrome exacerbated after natalizumab. Neurol Neuroimmunol NeuroInflammation 2015; 2: –3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Laule C, Vavasour IM, Kolind SH, et al. Magnetic resonance imaging of myelin. Neurotherapeutics 2007; 4: 460–484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Alonso-Ortiz E, Levesque IR, Pike GB. MRI-based myelin water imaging: a technical review. Magn Reson Med 2015; 73: 70–81. [DOI] [PubMed] [Google Scholar]
- 6.Beaulieu C. The basis of anisotropic water diffusion in the nervous system - A technical review. NMR Biomed 2002; 15: 435–455. [DOI] [PubMed] [Google Scholar]
- 7.Harsan LA, Poulet P, Guignard B, et al. Brain dysmyelination and recovery assessment by noninvasive in vivo diffusion tensor magnetic resonance imaging. J Neurosci Res 2006; 83: 392–402. [DOI] [PubMed] [Google Scholar]
- 8.Kleffner I, Deppe M, Mohammadi S, et al. Diffusion tensor imaging demonstrates fiber impairment in susac syndrome. Neurology 2008: 70–19(PART 2):1867–1869. [DOI] [PubMed] [Google Scholar]
- 9.Kleffner I, Deppe M, Mohammadi S, et al. Neuroimaging in susac’s syndrome: focus on DTI. J Neurol Sci 2010; 299: 92–96. [DOI] [PubMed] [Google Scholar]
- 10.Wang Y, Sun P, Wang Q, et al. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis. Brain 2015; 138: 1223–1238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wang Q, Wang Y, Liu J, et al. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer’s disease. NeuroImage Clin 2019; 22: 101767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Cross AH, Song SK. A new imaging modality to non-invasively assess multiple sclerosis pathology. J Neuroimmunol 2017; 304: 81–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Winklewski PJ, Sabisz A, Naumczyk Pet al. et al. Understanding the physiopathology behind axial and radial diffusivity changes-what do we know? Front Neurol 2018; 9: 92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kleffner I, Dörr J, Ringelstein M, et al. Diagnostic criteria for susac syndrome. J Neurol Neurosurg Psychiatry 2016; 87: 1287–1295. [DOI] [PubMed] [Google Scholar]
- 15.Prasloski T, Rauscher A, MacKay AL, et al. Rapid whole cerebrum myelin water imaging using a 3D GRASE sequence. Neuroimage 2012; 63: 533–539. [DOI] [PubMed] [Google Scholar]
- 16.Prasloski T, Mädler B, Xiang QSet al. et al. Applications of stimulated echo correction to multicomponent T2 analysis. Magn Reson Med 2012; 67: 1803–1814. [DOI] [PubMed] [Google Scholar]
- 17.Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004; 23(Suppl 1): S208–S219. 10.1016/j.neuroimage.2004.07.051 [DOI] [PubMed] [Google Scholar]
- 18.Abel S, Vavasour I, Lee LE, et al. Myelin damage in normal appearing white matter contributes to impaired cognitive processing speed in multiple sclerosis. J Neuroimaging 2020; 30: 205–211. [DOI] [PubMed] [Google Scholar]
- 19.Jenkinson M, Bannister P, Brady Met al. et al. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17: 825–841. [DOI] [PubMed] [Google Scholar]
- 20.Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001; 20: 45–57. [DOI] [PubMed] [Google Scholar]
- 21.Andersson JLR, Jenkinson M, Smith S. Non-Linear registration Aka spatial normalisation FMRIB technial report TR07JA2. FMRIB Analysis Group of the University of Oxford; 2007.
- 22.MRI Atlas of Human White Matter - Susumu Mori, S. Wakana, Peter C M van Zijl, L.M. Nagae-Poetscher - Google Books. Accessed July 8, 2020. https://books.google.ca/books?hl = en&lr = &id = ltwRYlvFNLIC&oi = fnd&pg = PR5&ots = gdOLiebLjp&sig = 0NJEuVwXD_O1OaGRd7mLqVyPbXc&redir_esc = y#v = onepage&q&f = false.
- 23.Liu F, Vidarsson L, Winter JDet al. et al. Sex differences in the human corpus callosum microstructure: a combined T2 myelin-water and diffusion tensor magnetic resonance imaging study. Brain Res 2010; 1343: 37–45. [DOI] [PubMed] [Google Scholar]
- 24.Dvorak A V, Swift-Lapointe T, Vavasour IM, et al. An atlas for human brain myelin content throughout the adult life span. Sci Reports 2021; 11:269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Faizy TD, Thaler C, Kumar D, et al. Heterogeneity of multiple sclerosis lesions in multislice myelin water imaging. PLoS One 2016; 11: e0151496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Abel S, Vavasour I, Lee LE, et al. Associations between findings From myelin water imaging and cognitive performance Among individuals With multiple sclerosis. JAMA Netw open 2020; 3: e2014220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Oh J, Han ET, Lee MCet al. et al. Multislice brain myelin water fractions at 3T in multiple sclerosis. J Neuroimaging 2007; 17: 156–163. [DOI] [PubMed] [Google Scholar]
- 28.Laule C, Vavasour IM, Moore GRW, et al. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study. J Neurol 2004; 251: 284–293. [DOI] [PubMed] [Google Scholar]
- 29.Agamanolis DP, Prayson RA, Asdaghi N, et al. Brain microvascular pathology in susac syndrome: an electron microscopic study of five cases. Ultrastruct Pathol 2019; 43: 229–236. [DOI] [PubMed] [Google Scholar]